Early pulmonary complications after hematopoietic stem cell transplantation in pediatric patients: Association with cytomegalovirus infection

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 8, 2009, Pages 545-551

  Lee, Ji Won ^a   Kang, Hyoung Jin ^a   Park, June Dong ^a   Shin, Hee Young ^a   Ahn, Hyo Seop ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

CMV infection; Hematopoietic stem cell transplantation; Pulmonary complications

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; DEFIBROTIDE; GANCICLOVIR; IMMUNOGLOBULIN; ITRACONAZOLE; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS; ANTIINFLAMMATORY AGENT; VIRUS ANTIGEN;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALLOTRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; INFANT; LUNG COMPLICATION; MALE; MORTALITY; MYCOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; VEIN OCCLUSION; AUTOTRANSPLANTATION; BLOOD; NEOPLASM; VIROLOGY;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; METHYLPREDNISOLONE; NEOPLASMS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 68849126556     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181983c9d     Document Type: Article

References (28)

1. Krowka MJ, Rosenow EC III, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest. 1985;87:237-246. (Pubitemid 15174060)
2. Breuer R, Lossos IS, Berkman N, et al. Pulmonary complications of bone marrow transplantation. Respir Med. 1993;87:571-579. (Pubitemid 23350165)
3. Carlson K, Backlund L, Smedmyr B, et al. Pulmonary function and complications subsequent to autologous bone marrow transplantation. Bone Marrow Transplant. 1994;14:805-811. (Pubitemid 24228748)
4. Huisman C, van der Straaten HM, Canninga-van Dijk MR, et al. Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease. Bone Marrow Transplant. 2006;38:561-566. (Pubitemid 44509549)
5. Lim DH, Lee J, Lee HG, et al. Pulmonary complications after hematopoietic stem cell transplantation. J Korean Med Sci. 2006;21:406-411. (Pubitemid 43925981)
6. Ho VT, Weller E, Lee SJ, et al. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7:223-229. (Pubitemid 32433249)
7. Crawford SW, Longton G, Storb R. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant. 1993;12:225-231. (Pubitemid 23268157)
8. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest. 1996;109:1066-1077. (Pubitemid 26113654)
9. Faber-Langendoen K, Caplan AL, McGlave PB. Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant. 1993;12:501-507. (Pubitemid 23328365)
10. Lamas A, Otheo E, Ros P, et al. Prognosis of child recipients of hematopoietic stem cell transplantation requiring intensive care. Intensive Care Med. 2003;29:91-96. (Pubitemid 36216388)
11. Khassawneh BY, White P Jr, Anaissie EJ, et al. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest. 2002;121:185-188. (Pubitemid 34114245)
12. Shorr AF, Moores LK, Edenfield WJ, et al. Mechanical ventilation in hematopoietic stem cell transplantation: can we effectively predict outcomes? Chest. 1999;116:1012-1018.
13. Kang HJ, Shin HY, Choi HS, et al. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Bone Marrow Transplant. 2004;34:939-943.
14. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-824. (Pubitemid 24082248)
15. Gorak E, Geller N, Srinivasan R, et al. Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival. Biol Blood Marrow Transplant. 2005;11:542-550. (Pubitemid 40862451)
16. Schmid I, Stachel D, Pagel P, et al. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients. Biol Blood Marrow Transplant. 2008;14:438-444.
17. Jones RJ, Lee KS, Beschorner WE, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44:778-783. (Pubitemid 18034278)
18. Boeckh M, Nichols WG, Papanicolaou G, et al. Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. Biol Blood Marrow Transplant. 2003;9:543-558. (Pubitemid 38351787)
19. Osarogiagbon RU, Defor TE, Weisdorf MA, et al. CMV antigenemia following bone marrow transplantation: risk factors and outcomes. Biol Blood Marrow Transplant. 2000;6:280-288.
20. Castagnola E, Cappelli B, Erba D, et al. Cytomegalovirus infection after bone marrow transplantation in children. Hum Immunol. 2004;65:416-422. (Pubitemid 38686765)
21. Boeckh M, Nichols WG. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood. 2004;103:2003-2008. (Pubitemid 38326213)
22. Tomonari A, Takahashi S, Ooi J, et al. Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan. Eur J Haematol. 2008;80:251-257. (Pubitemid 351253457)
23. Craddock C, Szydlo RM, Dazzi F, et al. Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis. Br J Haematol. 2001;112:228-236. (Pubitemid 32151176)
24. Broers AE, van Der Holt R, van Esser JW, et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood. 2000;95:2240-2245.
25. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis. 1990;12:S754-S766.
26. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349.
27. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131:954-963. (Pubitemid 46608692)
28. Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671-1684.